title: CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells.
abstract: Mutations in the WNT/beta-catenin pathway are responsible for initiating the majority of colorectal cancers (CRCs). We have previously shown that hyperactivation of this signaling by histone deacetylase inhibitors (HDACis) such as butyrate, a fermentation product of dietary fiber, promotes CRC cell apoptosis. The extent of association between beta-catenin and the transcriptional coactivator CREB-binding protein (CBP) influences WNT/catenin signaling and, therefore, colonic cell physiology. CBP functions as a histone acetylase (HAT); therefore, we hypothesized that the modulation of WNT/catenin activity by CBP modifies the ability of the HDACi butyrate to hyperinduce WNT signaling and apoptosis in CRC cells. Our findings indicate that CBP affects the hyperinduction of WNT activity by butyrate. ICG-001, which specifically blocks association between CBP and beta-catenin, abrogates the butyrate-triggered increase in the number of CRC cells with high levels of WNT/catenin signaling. Combination treatment of CRC cells with ICG-001 and butyrate results in cell type-specific effects on apoptosis. Further, both butyrate and ICG-001 repress CRC cell proliferation, with additive effects in suppressing cell growth. Our study strongly suggests that ICG-001-like agents would be effective against butyrate/HDACi-resistant CRC cells. Therefore, ICG-001-like agents may represent an important therapeutic option for CRCs that exhibit low-fold hyperactivation of WNT activity and apoptosis in the presence of HDACis. The findings generated from this study may lead to approaches that utilize modulation of CBP activity to facilitate CRC therapeutic or chemopreventive strategies.
authors.affiliation: 1. Department of Basic Sciences, The Commonwealth Medical College, 525 Pine Street, Scranton, PA 18509, USA.
authors.forename: Darina L
authors.initials: DL
authors.lastname: Lazarova
authors.forename: Christopher
authors.initials: C
authors.lastname: Chiaro
authors.forename: Terrence
authors.initials: T
authors.lastname: Wong
authors.forename: Eric
authors.initials: E
authors.lastname: Drago
authors.forename: Anthony
authors.initials: A
authors.lastname: Rainey
authors.forename: Shannon
authors.initials: S
authors.lastname: O'Malley
authors.forename: Michael
authors.initials: M
authors.lastname: Bordonaro
keywords: CBP; ICG-001; WNT; butyrate; colorectal cancer; fiber.
references.citation: Exp Cell Res. 2007 May 1;313(8):1652-66
references.pmid: 17359971
references.citation: Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3046-50
references.pmid: 7708772
references.citation: Oncogene. 2005 May 19;24(22):3619-31
references.pmid: 15782138
references.citation: Science. 1993 Dec 10;262(5140):1731-4
references.pmid: 8259518
references.citation: Nature. 1998 Oct 1;395(6701):521-5
references.pmid: 9774110
references.citation: Proc Nutr Soc. 1990 Jul;49(2):153-71
references.pmid: 2172992
references.citation: Curr Opin Cell Biol. 1999 Dec;11(6):745-52
references.pmid: 10600713
references.citation: Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5668-73
references.pmid: 17372190
references.citation: Mol Cancer Ther. 2002 Jun;1(8):639-49
references.pmid: 12479224
references.citation: Lancet. 2003 May 3;361(9368):1491-5
references.pmid: 12737857
references.citation: Cell. 1996 Aug 9;86(3):391-9
references.pmid: 8756721
references.citation: Mol Cell Biol. 2004 Apr;24(8):3404-14
references.pmid: 15060161
references.citation: Cell. 2000 Oct 13;103(2):311-20
references.pmid: 11057903
references.citation: Cancer Res. 1992 Nov 1;52(21):5906-12
references.pmid: 1327519
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12171-6
references.pmid: 16093313
references.citation: Med Res Rev. 2006 Jul;26(4):397-413
references.pmid: 16450343
references.citation: Int J Cancer. 2004 Jul 1;110(4):523-31
references.pmid: 15122584
references.citation: Cell. 2012 Jun 8;149(6):1245-56
references.pmid: 22682247
references.citation: Mol Cell. 1998 Nov;2(5):581-91
references.pmid: 9844631
references.citation: Cancer Res. 1994 Jun 15;54(12):3288-93
references.pmid: 8205551
references.citation: Science. 1997 Mar 21;275(5307):1787-90
references.pmid: 9065402
references.citation: J Cancer Res Clin Oncol. 2005 Oct;131(10):692-700
references.pmid: 16133571
references.citation: Lancet. 2003 May 3;361(9368):1496-501
references.pmid: 12737858
references.citation: Int J Cancer. 1995 Jan 27;60(3):400-6
references.pmid: 7829251
references.citation: Expert Opin Investig Drugs. 2005 Dec;14(12):1497-511
references.pmid: 16307490
references.citation: Cancer Res. 1997 Sep 1;57(17):3697-707
references.pmid: 9288776
references.citation: Clin Cancer Res. 2010 Jun 15;16(12):3153-62
references.pmid: 20530697
references.citation: EMBO J. 2007 May 2;26(9):2284-94
references.pmid: 17410209
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1552-6
references.pmid: 15941971
references.citation: Nat Rev Cancer. 2005 Sep;5(9):744-9
references.pmid: 16148886
references.citation: Hum Mol Genet. 2002 Jun 15;11(13):1549-60
references.pmid: 12045208
references.citation: Science. 1993 Dec 10;262(5140):1734-7
references.pmid: 8259519
references.citation: Gut. 1987 Oct;28(10):1221-7
references.pmid: 3678950
references.citation: Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12682-7
references.pmid: 15314234
references.citation: EMBO J. 2000 Apr 17;19(8):1839-50
references.pmid: 10775268
references.citation: Blood. 1999 Mar 1;93(5):1524-33
references.pmid: 10029580
references.citation: Drug Discov Today. 2005 Nov 1;10(21):1467-74
references.pmid: 16243267
references.citation: Oncol Res. 2008;17(1):1-9
references.pmid: 18488710
references.citation: Adv Drug Deliv Rev. 2010 Sep 30;62(12):1149-55
references.pmid: 20920541
references.citation: Curr Opin Cell Biol. 2007 Apr;19(2):150-8
references.pmid: 17306971
references.citation: EMBO J. 1996 Sep 2;15(17):4526-36
references.pmid: 8887544
references.citation: BMC Cancer. 2006 May 10;6:124
references.pmid: 16686938
references.citation: Eur J Cancer. 2002 Sep;38(14):1937-45
references.pmid: 12204677
references.citation: Nature. 1996 Aug 15;382(6592):638-42
references.pmid: 8757136
references.citation: Science. 1997 Mar 21;275(5307):1784-7
references.pmid: 9065401
references.citation: Cell Growth Differ. 1999 Oct;10(10):713-20
references.pmid: 10547075